Literature DB >> 1536847

Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsion: proposal of a putative model for the pre-beta high-density lipoprotein pathway.

H Hara1, S Yokoyama.   

Abstract

Lipid microemulsion of phospholipid and triglyceride with the size of low-density lipoprotein was capable of removing cholesterol from cholesterol-loaded mouse peritoneal macrophages, resulting in reduction of intracellularly accumulated cholesteryl ester. Apolipoproteins (apo) A-I, A-II, C-III, and E bound to the surface of the microemulsion did not modulate the interaction of the microemulsion with the cells in terms of the cholesterol efflux. The cholesterol removal by the microemulsion was enhanced by some 30% only when apoA-I, -A-II, and -E were present in excess to provide their free forms in the medium, but apoC-III did not show such an effect even by its excess amount. The kinetics including the results with apoC-III were consistent with a model that the apparent enhancement was due to generation of pre-beta high-density lipoprotein (HDL)-like particles upon the interaction of free apolipoproteins with macrophages [Hara, H., & Yokoyama, S. (1991) J. Biol. Chem. 266, 3080-3086]. However, pre beta-HDL-like particle was not detected after 6- and 24-h incubation in the medium where cholesterol efflux to the emulsion was maximally enhanced by the apolipoproteins, and cholesterol and phospholipids removed from the cells were all found with the microemulsions. It was also shown separately that the lipids in pre beta-HDL-like particles generated by apoA-I and macrophages were rapidly, within the order of minutes, transferred to the apo-lipoprotein-covered microemulsions when they were incubated together. Thus, the data were consistent with a model that the free form of certain apolipoproteins, such as apoA-I, -A-II, and -E but not apoC-III, generates pre beta-HDL-like particles with cellular lipids in situ and these particles act as mediators for cholesterol transfer from the cells to other lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536847     DOI: 10.1021/bi00122a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Impact of self-association on function of apolipoprotein A-I.

Authors:  Shobini Jayaraman; Sumiko Abe-Dohmae; Shinji Yokoyama; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

2.  Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.

Authors:  V M Atger; M de la Llera Moya; G W Stoudt; W V Rodrigueza; M C Phillips; G H Rothblat
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

Review 4.  Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.

Authors:  Maki Tsujita; Anna Wolska; Daniel A P Gutmann; Alan T Remaley
Journal:  Curr Atheroscler Rep       Date:  2018-11-05       Impact factor: 5.113

5.  Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.

Authors:  Hongwen Zhou; Zhiqiang Li; David L Silver; Xian-Cheng Jiang
Journal:  Biochim Biophys Acta       Date:  2006-09-20

6.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.

Authors:  A J Mendez; G M Anantharamaiah; J P Segrest; J F Oram
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

7.  Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

Authors:  V Atger; M de la Llera Moya; M Bamberger; O Francone; P Cosgrove; A Tall; A Walsh; N Moatti; G Rothblat
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

8.  HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.

Authors:  Fumihiko Matsuura; Nan Wang; Wengen Chen; Xian-Cheng Jiang; Alan R Tall
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

9.  The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

Authors:  S Lusa; M Jauhiainen; J Metso; P Somerharju; C Ehnholm
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

10.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.